{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T14:46:25Z","timestamp":1786373185596,"version":"build-2736575974"},"reference-count":11,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["CJASN"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.2215\/cjn.06000521","type":"journal-article","created":{"date-parts":[[2021,7,12]],"date-time":"2021-07-12T12:15:32Z","timestamp":1626092132000},"page":"1002-1004","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Shining More Light on RAS Inhibition during the COVID-19 Pandemic"],"prefix":"10.2215","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6241-6816","authenticated-orcid":false,"given":"Fitra","family":"Rianto","sequence":"first","affiliation":[{"name":"Division of Nephrology, Department of Medicine, Duke University School of Medicine, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2075-2691","authenticated-orcid":false,"given":"Matthew A.","family":"Sparks","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, Duke University School of Medicine, Durham, North Carolina"},{"name":"Renal Section, Durham Veterans Affairs Health Care System, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,7]]},"reference":[{"key":"B1-20241015","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature"},{"key":"B2-20241015","doi-asserted-by":"crossref","first-page":"714","DOI":"10.2215\/CJN.03530320","article-title":"Sound science before quick judgement regarding RAS blockade in COVID-19","volume":"15","author":"Sparks","year":"2020","journal-title":"Clin J Am Soc Nephrol"},{"key":"B3-20241015","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/S2213-2600(20)30116-8","article-title":"Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?","volume":"8","author":"Fang","year":"2020","journal-title":"Lancet Respir Med"},{"key":"B4-20241015","doi-asserted-by":"crossref","first-page":"m810","DOI":"10.1136\/bmj.m810","article-title":"Preventing a COVID-19 pandemic","volume":"368","author":"Watkins","year":"2020","journal-title":"BMJ"},{"issue":"Suppl 1","key":"B5-20241015","doi-asserted-by":"crossref","first-page":"i48","DOI":"10.1093\/ckj\/sfab026","article-title":"Renin-angiotensin system blockade in the COVID-19 pandemic","volume":"14","author":"Cohen","year":"2021","journal-title":"Clin Kidney J"},{"key":"B6-20241015","doi-asserted-by":"crossref","first-page":"e213594","DOI":"10.1001\/jamanetworkopen.2021.3594","article-title":"Association between renin-angiotensin-aldosterone system inhibitors and clinical outcomes in patients with COVID-19: A systematic review and meta-analysis","volume":"4","author":"Baral","year":"2021","journal-title":"JAMA Netw Open"},{"key":"B7-20241015","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S2213-2600(20)30558-0","article-title":"Continuation versus discontinuation of renin-angiotensin system inhibitors in patients admitted to hospital with COVID-19: A prospective, randomised, open-label trial","volume":"9","author":"Cohen","year":"2021","journal-title":"Lancet Respir Med"},{"key":"B8-20241015","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1001\/jama.2020.25864","article-title":"Effect of discontinuing vs continuing angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on days alive and out of the hospital in patients admitted with COVID-19: A randomized clinical trial","volume":"325","author":"Lopes","year":"2021","journal-title":"JAMA"},{"key":"B9-20241015","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.2215\/CJN.18961220","article-title":"Renin-angiotensin system blockers and the risk of COVID-19\u2013related mortality in patients with kidney failure","volume":"16","author":"Soler","year":"2021","journal-title":"Clin J Am Soc Nephrol"},{"key":"B10-20241015","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1016\/j.kint.2020.07.030","article-title":"Outcomes of patients with end-stage kidney disease hospitalized with COVID-19","volume":"98","author":"Ng","year":"2020","journal-title":"Kidney Int"},{"key":"B11-20241015","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.1111\/ajt.16185","article-title":"COVID-19 and kidney transplantation: Results from the TANGO International Transplant Consortium","volume":"20","author":"Cravedi","year":"2020","journal-title":"Am J Transplant"}],"container-title":["Clinical Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.2215\/CJN.06000521","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T13:43:20Z","timestamp":1786369400000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.2215\/CJN.06000521"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":11,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.2215\/cjn.06000521","relation":{},"ISSN":["1555-9041","1555-905X"],"issn-type":[{"value":"1555-9041","type":"print"},{"value":"1555-905X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7]]}}}